Punjab Chemicals & Crop Protection Ltd posted a 14% year-on-year revenue growth to ₹1,030 crore in FY2026. The company recommended a final dividend of ₹3 per share and plans ₹100 crore capex for new manufacturing blocks.
Punjab Chemicals & Crop Protection Ltd Financial Highlights
Consolidated revenue for FY2026 reached ₹1,030 crore, marking a 14% year-on-year increase. The company reported earnings before interest, taxes, depreciation, and amortization (EBITDA) of ₹118 crore, with an EBITDA margin of 11.5%. Profit after tax (PAT) stood at ₹64 crore, translating to a PAT margin of 6.20%. The return on capital employed (ROCE) was 17.96%, and the debt-to-equity ratio remained healthy at 0.34.
Reader Takeaway: Strong revenue growth and planned capex provide growth drivers; pricing pressures remain a concern.
What just happened
Punjab Chemicals & Crop Protection Ltd announced its fiscal year 2026 financial results, showcasing a 14% year-on-year increase in consolidated revenue to ₹1,030 crore. The company also declared an EBITDA of ₹118 crore and a Profit After Tax (PAT) of ₹64 crore. Alongside the financial performance, the Board recommended a final dividend of ₹3 per equity share (30% payout) for FY2026.
Why this matters
The 14% revenue growth indicates sustained demand for the company's products despite challenging market conditions mentioned by management. The proposed dividend offers a direct return to shareholders. Furthermore, the planned capital expenditure of ₹100 crore signals investment in future growth, potentially enhancing production capacity and efficiency.
The backstory
In FY2026, Punjab Chemicals navigated pricing pressures, volatile raw material costs, and adverse weather. The company's diversified business model helped maintain stability. New products contributed between 15-16% to revenue, with plans to boost this to 18-20% in two years. R&D investments are set to double.
What changes now
The company plans to invest ₹100 crore in two new manufacturing blocks and to debottleneck existing facilities. Three MoUs with global customers for high-value agrochemicals and intermediates are set for commercialization within 12-18 months. Management aims to offset legacy molecule pricing issues by focusing on higher-value products.
Risks to watch
Key risks include persistent pricing pressures on older products and supply-demand imbalances in the industry. The successful and timely execution of new MoUs and the operationalization of new manufacturing capacities are critical for achieving projected growth.
Peer comparison
Peer performance in the agrochemical and specialty chemical sectors can vary based on product portfolios and geographic exposure. While specific peer data is not provided in the filing, Punjab Chemicals' focus on diversifying into higher-value products is a common strategy to mitigate margin pressures.
Context metrics (time-bound)
- Consolidated Revenue (FY2026): ₹1,030 crore (up 14% YoY)
- EBITDA (FY2026): ₹118 crore (11.5% margin)
- PAT (FY2026): ₹64 crore (6.20% margin)
- Debt-to-Equity Ratio: 0.34
- Capex Planned: ₹100 crore
- New Products Contribution: 15-16% of revenue (target 18-20% in 2 years)
- Final Dividend: ₹3 per share
What to track next
Investors should monitor the progress of the new manufacturing block development, the timeline for commercialization of the MoUs, and the increasing contribution of new, higher-value products to the company's overall revenue. Management's ability to offset legacy molecule pricing challenges will also be key.
